About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen

NCT00002269·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

HEM Research

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients must have:
HIV-1 seropositivity.
Absolute number of T4 cells 100-300 cells/mm3.
Given informed consent.
Zidovudine (AZT) therapy for 6 months prior to study entry.
At least one of the listed HIV-related clinical symptoms or opportunistic infections:
weight loss \> 10 percent, unexplained diarrhea, unexplained intermittent fever, oral candidiasis \> 1 month, decreased Karnofsky, oral hairy leukoplakia, chronic fatigue.

You may not be if

Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Evidence of AIDS.
Intercurrent acute medical disorder.
Concurrent Medication:
Excluded:
Chemotherapy for Kaposi's sarcoma (KS).
Aspirin.
Non-steroidal anti-inflammatory drugs.
Patients with the following are excluded:
Inability to return for treatment and evaluation for 12 months.
Intercurrent acute medical disorder.
Evidence of AIDS.
Receiving chemotherapy for Kaposi's sarcoma (KS).
Unwilling or unable to give informed consent.
Required:
Zidovudine (AZT).
Required at least 6 months prior to study entry:
Zidovudine (AZT).
Active drug abuse.

The record

StatusCompleted

PhaseNo phase

Taking part—

Started—

UpdatedJun 24, 2005

Conditions

Where5

Miami Veterans Administration Med Ctr
Miami, Florida, United States
Oregon Health Sciences Univ
Portland, Oregon, United States
MCP Hahnemann Univ Hosp
Philadelphia, Pennsylvania, United States

Clareo Health | A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen